The use of Ephedra herbs in the treatment of COVID-19
- PMID: 37654998
- PMCID: PMC10465882
- DOI: 10.22038/AJP.2022.21607
The use of Ephedra herbs in the treatment of COVID-19
Abstract
Objective: Ephedra herbs are the only extant genus in its family, Ephedraceae, and order, Ephedrales. It has been prescribed in traditional medicine for improving headaches and respiratory infections. On the other hand, because the coronavirus disease 2019 (COVID-19) causes respiratory problems and COVID-19 pandemic is the most widespread outbreak that has affected humanity in the last century, the current review aims using literature search to investigate the effects of the Ephedra herbs compounds on COVID-19 to supply a reference for its clinical application in the inhibition and remedy of COVID-19.
Materials and methods: This review was performed using articles published in various databases, including Web of Science, PubMed, Scopus, and Google Scholar, without a time limit. For this paper, the following keywords were used: "Ephedra", "coronavirus disease 2019", "COVID-19", "Severe acute respiratory syndrome coronavirus 2" or "SARS CoV 2".
Results: The results of this review show that the Ephedra herbs have effectiveness on COVID-19 and its compounds can bind to angiotensin-converting enzyme 2 (ACE2) with a high affinity and act as a blocker and prevent the binding of the virus.
Conclusion: Some plants used in traditional medicine, including the Ephedra herbs, with their active compounds, can be considered a candidate with high potential for the control and prevention of COVID-19.
Keywords: COVID-19; Ephedra; Respiratory infections; Traditional medicines.
Conflict of interest statement
The authors have declared that there is no conflict of interest.
Similar articles
-
Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents.J Ethnopharmacol. 2021 Oct 5;278:114303. doi: 10.1016/j.jep.2021.114303. Epub 2021 Jun 5. J Ethnopharmacol. 2021. PMID: 34102269 Free PMC article.
-
Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach.Anal Bioanal Chem. 2021 May;413(11):2995-3004. doi: 10.1007/s00216-021-03233-7. Epub 2021 Feb 19. Anal Bioanal Chem. 2021. PMID: 33608752 Free PMC article.
-
Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications.Phytomedicine. 2022 Apr;98:153930. doi: 10.1016/j.phymed.2022.153930. Epub 2022 Jan 5. Phytomedicine. 2022. PMID: 35114450 Free PMC article.
-
Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).Curr Pharm Des. 2021;27(38):3996-4007. doi: 10.2174/1381612827666210705160130. Curr Pharm Des. 2021. PMID: 34225607 Review.
-
Potential Targets for Treatment of Coronavirus Disease 2019 (COVID-19): A Review of Qing-Fei-Pai-Du-Tang and Its Major Herbs.Am J Chin Med. 2020;48(5):1051-1071. doi: 10.1142/S0192415X20500512. Am J Chin Med. 2020. PMID: 32668969 Review.
Cited by
-
SARS-CoV-2 infection increases airway bleeding risk in patients after tracheostomies.Virol J. 2024 Mar 7;21(1):61. doi: 10.1186/s12985-024-02320-2. Virol J. 2024. PMID: 38454485 Free PMC article.
-
Safety and Efficacy of Ephedrine Alkaloids-Free Ephedra Herb Extract (EFE) for Mild COVID-19: A Double-Blind, Placebo-Controlled, Randomized Comparative Trial.Microorganisms. 2025 Mar 12;13(3):641. doi: 10.3390/microorganisms13030641. Microorganisms. 2025. PMID: 40142533 Free PMC article.
References
-
- Al-Snafi AE. Nutritional and pharmacological importance of Ficus carica-A review. IOSR J Pharm. 2017;7:33–48.
-
- Arokiaraj S, Vincent S, Vannam DK. Touting traditional knowledge and herbal medicine to combat and prevent COVID-19. Curr Pharm Biotechnol. 2020;21:1280–1281. - PubMed
-
- Askew RR, Nieves-Aldrey JL. Eupelmidae (Hymenoptera, Chalcidoidea) of Iberia and the Canary Islands: an annotated checklist with descriptions of some previously unrecognised males and a new species of Calosota Curtis, 1836. Graellsia. 2017;73:1–17.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous